Waters Parkerson & Co., LLC Eli Lilly & CO Transaction History

Waters Parkerson & Co., LLC

$1.88 Billion
Q2 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 10,505 shares of LLY stock, worth $9.32 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

10,505

Previous 10,811 2.83%

Holding current value

$9.32 Million

Previous $8.41 Million 13.08%

% of portfolio

0.51%

Previous 0.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $221,810 - $278,166	-306 Reduced 2.83%	10,505 $9.51 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $274,188 - $366,825	463 Added 4.47%	10,811 $8.41 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $237,911 - $280,465	453 Added 4.58%	10,348 $6.03 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $66,509 - $91,692	-153 Reduced 1.52%	9,895 $5.32 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $8,768 - $11,724	-25 Reduced 0.25%	10,048 $4.71 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $288,430 - $336,078	-897 Reduced 8.18%	10,073 $3.69 Million
Q3 2022 Nov 04, 2022	BUY	$296.48 - $337.87 $85,979 - $97,982	290 Added 2.72%	10,970 $3.55 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $32,053 - $37,636	115 Added 1.09%	10,680 $3.46 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $33,091 - $41,124	-141 Reduced 1.32%	10,565 $3.03 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $11,692 - $14,510	52 Added 0.49%	10,706 $2.96 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $96,396 - $118,628	-435 Reduced 3.92%	10,654 $2.46 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $14,286 - $17,682	120 Added 1.09%	11,089 $1.54 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $42,768 - $52,972	-400 Reduced 3.52%	10,969 $1.44 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $110,790 - $129,320	-1,000 Reduced 8.08%	11,369 $1.26 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $369,103 - $434,462	-3,316 Reduced 21.14%	12,369 $1.61 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $63,540 - $71,184	-600 Reduced 3.68%	15,685 $1.82 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $11,161 - $13,950	130 Added 0.8%	16,285 $1.75 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $50,567 - $58,035	-668 Reduced 3.97%	16,155 $1.38 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $1,855 - $2,190	-25 Reduced 0.15%	16,823 $1.3 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $20,485 - $21,972	-250 Reduced 1.46%	16,848 $1.42 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $240,843 - $267,312	3,125 Added 22.36%	17,098 $1.46 Million
Q2 2017 Aug 11, 2017	BUY	N/A	13,973	13,973 $1.15 Million

Others Institutions Holding LLY

# of Institutions

3,870

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $843B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Eli Lilly & CO Transaction History